Bard® InLay® Ureteral Stent with NiCore™ Guidewire 776622Recalls & reported problems
C. R. Bard, Inc. · INLAY URETERAL STENT W/NITINOL GUIDEWIRE · Class 2 · Implant
All models of Bard InLay Ureteral Stent with NiCore Guidewire (7)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 10801741014250), received between Nov 3, 2021 and Nov 4, 2021 — classified as 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Biocompatibility” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Biocompatibility1
- Calcified1
- Device Dislodged or Dislocated1
- Migration1
- Patient Device Interaction Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 4, 2021Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT PATIENT EXPERIENCED STONE FORMATION, URETERAL REFLUX AND STENT DISLODGEMENT, MIGRATION BY URETERAL STENT. UNKNOWN MEDICAL INTERVENTION WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12751228 ↗MalfunctionNov 3, 2021Calcified; Calcified
IT WAS REPORTED THAT PATIENT EXPERIENCED STONE FORMATION, URETERAL REFLUX AND STENT DISLODGEMENT, MIGRATION BY URETERAL STENT. UNKNOWN MEDICAL INTERVENTION WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12748952 ↗InjuryNov 3, 2021Biocompatibility; Patient Device Interaction Problem; Biocompatibility; Patient Device Interaction Problem
IT WAS REPORTED THAT PATIENT EXPERIENCED STONE FORMATION, URETERAL REFLUX AND STENT DISLODGEMENT, MIGRATION BY URETERAL STENT. UNKNOWN WHAT MEDICAL INTERVENTION WAS PROVIDED.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MAUDE report 12745816 ↗MalfunctionNov 3, 2021Migration; Migration
IT WAS REPORTED THAT PATIENT EXPERIENCED STONE FORMATION, URETERAL REFLUX AND STENT DISLODGEMENT, MIGRATION BY URETERAL STENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12745345 ↗
Other STENT, URETERAL devices
- Bard® InLay Optima® Ureteral Stent 788426C. R. Bard, Inc. · STENT, URETERAL1 recall100 reports
- Bard® InLay Optima® Ureteral Stent 788626C. R. Bard, Inc. · STENT, URETERAL122 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777626C. R. Bard, Inc. · STENT, URETERAL118 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777426C. R. Bard, Inc. · STENT, URETERAL108 reports
- Bard® InLay® Ureteral Stent 778626C. R. Bard, Inc. · STENT, URETERAL100 reports
- Percuflex™ Plus M0061752530Boston Scientific Corporation · STENT, URETERAL1 death99 reports
- Contour VL™ M0061801560Boston Scientific Corporation · STENT, URETERAL1 recall45 reports
- Polaris™ Ultra M0061921330Boston Scientific Corporation · STENT, URETERAL71 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page